UNC to lead schizophrenia study
16th Nov 2006, 19:42 GMT
The University of North Carolina at Chapel Hill's School of Medicine will lead a new clinical trial to study the side effects of drugs commonly used to treaty schizophrenia.
Latest news from Latest news from Triangle Business Journal:
- Eisai breaks ground on $90M Durham expansion
- Icagen losses mount in 3Q
- Xerium stock plunges after earnings report
- Golden Leaf chips in $223,000 for Sanford dental program
- UNC names Butch Davis head football coach
- GSK reaches deal to end patent dispute
- Despite hikes, N.C. teacher pay still below average
- Clearwire to make Triangle debut, hire 50 employees
- Trimeris swaps CEOs, says it will slash jobs
- SunTrust announces CEO change